Positive effects of PARP-1 inhibition in KRAS-mutated intrahepatic cholangiocarcinoma is mediated by CHK1 kinase

被引:0
|
作者
Castven, Darko [1 ]
Keggenhoff, Friederike [2 ]
Stojkovic, Stojan [1 ]
Becker, Diana
Castven, Jovana [1 ]
Zimpel, Carolin [1 ]
Straub, Beate [2 ]
Langer, Harald [1 ]
Hahnel, Patrizia
Kindler, Thomas
Fahrer, Jörg [3 ]
Rourke, Colm O. [4 ]
Ma, Lichun [5 ]
Wang, Xin W. [5 ]
Gaiser, Timo [6 ]
Matter, Matthias [7 ]
Sina, Christian [1 ]
Derer, Stefanie [1 ]
Roessler, Stephanie [8 ]
Kaina, Bernd [2 ]
Andersen, Jesper [4 ]
Galle, Peter [2 ]
Marquardt, Jens [1 ]
机构
[1] Univ Klinikum Schleswig Holstein, Campus Lubeck, Lubeck, Germany
[2] Johannes Gutenberg Univ Mainz, Univ Med, Mainz, Germany
[3] Tech Univ Kaiserslautern, Kaiserslautern, Germany
[4] Biotech Res & Innovat Ctr, Copenhagen, Denmark
[5] NCI, NIH, Bethesda, MD USA
[6] Univ Med Mannheim, Mannheim, Germany
[7] Univ Spital Basel, Basel, Switzerland
[8] Heidelberg Univ, Heidelberg, Germany
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
SAT-230
引用
收藏
页码:S536 / S537
页数:2
相关论文
共 50 条
  • [31] Identifying GSK3ß inhibition as a potent adjuvant to PARP inhibition in IDH1-mutated cholangiocarcinoma cells
    Sato, Sara
    Yano, Hiromu
    Yamamoto, Masahiro
    CANCER SCIENCE, 2025, 116 : 1732 - 1732
  • [32] HPV-positive HNSCC cell lines but not primary human fibroblasts are radiosensitized by the inhibition of Chk1
    Busch, Chia-Jung
    Kriegs, Malte
    Laban, Simon
    Tribius, Silke
    Knecht, Rainald
    Petersen, Cordula
    Dikomey, Ekkehard
    Rieckmann, Thorsten
    RADIOTHERAPY AND ONCOLOGY, 2013, 108 (03) : 495 - 499
  • [33] Chk1 inhibition after replicative stress causes a double strand break response mediated primarily by DNA-dependent protein kinase
    McNeely, Samuel
    Conti, Chiara
    Sheikh, Tahir
    Pommier, Yves
    Schwartz, Gary
    Tse, Archie
    CANCER RESEARCH, 2009, 69
  • [34] Involvement of ATM-Mediated Chk1/2 and JNK Kinase Signaling Activation in HKH40A-Induced Cell Growth Inhibition
    Wang, Ziqiu
    Wang, Meifang
    Kar, Sid
    Carr, Brian I.
    JOURNAL OF CELLULAR PHYSIOLOGY, 2009, 221 (01) : 213 - 220
  • [35] Targeting the ATR/CHK1 Axis with PARP Inhibition Results in Tumor Regression in BRCA-Mutant Ovarian Cancer Models
    Kim, Hyoung
    George, Erin
    Ragland, Ryan L.
    Rafail, Stavros
    Zhang, Rugang
    Krepler, Clemens
    Morgan, Mark A.
    Herlyn, Meenhard
    Brown, Eric J.
    Simpkins, Fiona
    CLINICAL CANCER RESEARCH, 2017, 23 (12) : 3097 - 3108
  • [36] Chk1 inhibition after replicative stress activates a double strand break response mediated by ATM and DNA-dependent protein kinase
    McNeely, Samuel
    Conti, Chiara
    Sheikh, Tahir
    Patel, Himali
    Zabludoff, Sonya
    Pommier, Yves
    Schwartz, Gary
    Tse, Archie
    CELL CYCLE, 2010, 9 (05) : 995 - 1004
  • [37] Inhibition of Chk1 Kinase Sensitizes Leukemia and Lymphoma Cell Lines with TP53 Mutations to Chemotherapy
    Zemanova, Jana
    Sebejova, Ludmila
    Hylse, Ondrej
    Paruch, Kamil
    Pavlova, Sarka
    Mayer, Jiri
    Pospisilova, Sarka
    Trbusek, Martin
    BLOOD, 2012, 120 (21)
  • [38] Inhibition of the mutated c-KIT kinase in AML1-ETO-positive leukemia cells restores sensitivity to PARP inhibitor
    Nieborowska-Skorska, Margaret
    Paietta, Elisabeth M.
    Levine, Ross L.
    Fernandez, Hugo F.
    Taliman, Martin S.
    Litzow, Mark R.
    Skorski, Tomasz
    BLOOD ADVANCES, 2019, 3 (23) : 4050 - 4054
  • [39] BRAF Inhibitor-Driven Tumor Proliferation in a KRAS-Mutated Colon Carcinoma Is Not Overcome by MEK1/2 Inhibition
    Andrews, Miles C.
    Behren, Andreas
    Chionh, Fiona
    Mariadason, John
    Vella, Laura J.
    Do, Hongdo
    Dobrovic, Alexander
    Tebbutt, Niall
    Cebon, Jonathan
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (35) : E448 - E451
  • [40] Inhibition of CHK 1 (Checkpoint Kinase 1) Elicits Therapeutic Effects in pulmonary Arteria Hypenension
    Bourgeois, Alice
    Bonnet, Sebastien
    Breuils-Bonnet, Sandra
    Habbout, Karima
    Paradis, Renee
    Tremblay, Eve
    lampron, Marie-Claude
    Orcholski, Mark E.
    Potus, Francois
    Bertero, Thomas
    Peterlini, Thibaut
    Chan, Stephen Y.
    Norris, Karen A.
    Paulin, Roxane
    Provencher, Steeve
    Boucherat, Olivier
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2019, 39 (08) : 1667 - 1681